<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01345760</url>
  </required_header>
  <id_info>
    <org_study_id>1-Sand</org_study_id>
    <nct_id>NCT01345760</nct_id>
  </id_info>
  <brief_title>Expression Levels of RISC and Microprocessor Complex Components in Epithelial Skin Cancer</brief_title>
  <official_title>Expression Levels of RNA-induced Silencing Complex (RISC) Components TARBP1, TARBP2, Argonaute-1, Argonaute-2, PACT and Microprocessor Complex Component DGCR8 in Epithelial Skin Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ruhr University of Bochum</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ruhr University of Bochum</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      MicroRNAs (miRNAs) are very small endogenous RNA molecules about 22-25 nucleotides in length,
      capable of post-transcriptional gene regulation. miRNAs bind to their target messenger RNAs
      (mRNAs), leading to cleavage or suppression of target mRNA translation based on the degree of
      complementarity. miRNAs have recently been shown to play pivotal roles in diverse
      developmental and cellular processes and linked to a variety of skin diseases and cancers. In
      the present study, the investigators examines the expression profiles of the microprocessor
      complex subunit DGCR8 and the RISC components TARBP1, TARBP2, argonaute-1, argonaute-2 and
      PACT in epithelial skin cancer and its premalignant stage.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with premalignant actinic keratoses, basal cell carcinomas and squamous cell
      carcinomas were included in the study. Punch biopsies were harvested from the center of the
      tumors, from sites of healthy skin and a healthy control group. DGCR8, TARBP1, TARBP2,
      argonaute-1, argonaute-2 and PACT mRNA expression levels were detected by quantitative
      real-time reverse transcriptase polymerase chain reaction.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">44</enrollment>
  <condition>Skin Cancer</condition>
  <arm_group>
    <arm_group_label>Basal Cell Carcinoma</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Squamous Cell Carcinoma</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Actinic Keratosis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy non-lesional skin</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      human skin
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with epithelial skin cancer and pre-malignant stages
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  epithelial skin cancer

        Exclusion Criteria:

          -  other known previous malignancies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Falk G Bechara, PD Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum</name>
      <address>
        <city>Bochum</city>
        <state>NRW</state>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Sand M, Skrygan M, Georgas D, Arenz C, Gambichler T, Sand D, Altmeyer P, Bechara FG. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog. 2012 Nov;51(11):916-22. doi: 10.1002/mc.20861. Epub 2011 Oct 24.</citation>
    <PMID>22025453</PMID>
  </results_reference>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2011</study_first_submitted>
  <study_first_submitted_qc>April 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 2, 2011</study_first_posted>
  <last_update_submitted>October 15, 2012</last_update_submitted>
  <last_update_submitted_qc>October 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ruhr University of Bochum</investigator_affiliation>
    <investigator_full_name>Michael Sand</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Basal Cell Carcinoma</keyword>
  <keyword>Squamous Cell Carcinoma</keyword>
  <keyword>Actinic Keratosis</keyword>
  <keyword>microRNA</keyword>
  <keyword>Dicer</keyword>
  <keyword>Drosha</keyword>
  <keyword>RISC</keyword>
  <keyword>microprocessor complex</keyword>
  <keyword>Argonaute</keyword>
  <keyword>DGCR8</keyword>
  <keyword>TARBP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

